WC
VIVE

Wexford Capital’s VIVEVE MED INC VIVE Stock Holding History

Wexford Capital’s Portfolio VIVE Stock Details VIVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-349
Closed -$950K – 180
2018
Q2 		$950K Sell
349
-349
-50% -$1.01M 0.06% 89
2018
Q1 		$2.56M Buy
698
+421
+152% +$1.83M 0.19% 51
2017
Q4 		$1.37M Hold
277
– – 0.12% 80
2017
Q3 		$1.45M Hold
277
– – 0.12% 71
2017
Q2 		$1.99M Sell
277
-500
-64% -$3.73M 0.15% 66
2017
Q1 		$4.92M Buy
777
+150
+24% +$730K 0.4% 40
2016
Q4 		$3.23M Hold
627
– – 0.33% 42
2016
Q3 		$3.62M Hold
627
– – 0.59% 53
2016
Q2 		$2.06M Buy
+627
New +$2.92M 0.36% 60

Other funds holding VIVE

NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PC
Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return
MIH
Meitav Investment House Bene-Beraq, Israel $14.9B AUM 46.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wexford Capital's VIVE Position: Q3 2018 in Review

Wexford Capital sold out of VIVEVE MED INC (VIVE) in Q3 2018, closing a stake of 349 shares — an estimated $950K sold.

Wexford Capital first reported a position in VIVE in Q2 2016 and held it in 9 quarters. The position peaked at $4.92M in Q1 2017. 36 funds tracked by Wall St. Rank hold VIVE as of Q3 2018.

  • Wexford Capital reported no remaining VIVEVE MED INC position as of Q3 2018 after selling out during the quarter.
  • Wexford Capital sold 349 VIVEVE MED INC shares in Q3 2018, an estimated $950K.
  • Wexford Capital first reported a position in VIVEVE MED INC in Q2 2016 and held it in 9 quarters.
  • Wexford Capital's VIVEVE MED INC position peaked at $4.92M in Q1 2017.
  • 36 funds tracked by Wall St. Rank held VIVEVE MED INC as of Q3 2018.

Based on Wexford Capital's 13F filing for Q3 2018, filed 14 Nov 2018.